Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Imidazole propionate is a driver and therapeutic target in atherosclerosis.

  • Mastrangelo, Annalaura
  • Robles-Vera, Iñaki
  • Mañanes, Diego
  • Galán, Miguel
  • Femenía-Muiña, Marcos
  • Redondo-Urzainqui, Ana
  • Barrero-Rodríguez, Rafael
  • Papaioannou, Eleftheria
  • Amores-Iniesta, Joaquín
  • Devesa, Ana
  • Lobo-González, Manuel
  • Carreras, Alba
  • Beck, Katharina R
  • Ivarsson, Sophie
  • Gummesson, Anders
  • Georgiopoulos, Georgios
  • Rodrigo-Tapias, Manuel
  • Martínez-Cano, Sarai
  • Fernández-López, Ivan
  • Nuñez, Vanessa
  • Ferrarini, Alessia
  • Inohara, Naohiro
  • Stamatelopoulos, Kimon
  • Benguría, Alberto
  • Cibrian, Danay
  • Sánchez-Madrid, Francisco
  • Alonso-Herranz, Vanesa
  • Dopazo, Ana
  • Barbas, Coral
  • Vázquez, Jesús
  • López, Juan Antonio
  • González-Martín, Alicia
  • Nuñez, Gabriel
  • Stellos, Konstantinos
  • Bergström, Göran
  • Bäckhed, Fredrik
  • Fuster, Valentín
  • Ibañez, Borja
  • Sancho, David
Atherosclerosis is the main underlying cause of cardiovascular diseases. Its prevention is based on the detection and treatment of traditional cardiovascular risk factors. However, individuals at risk for early vascular disease often remain unidentified. Recent research has identified new molecules in the pathophysiology of atherosclerosis, highlighting the need for alternative disease biomarkers and therapeutic targets to improve early diagnosis and therapy efficacy. Here, we observed that imidazole propionate (ImP), produced by microorganisms, is associated with the extent of atherosclerosis in mice and in two independent human cohorts. Furthermore, ImP administration to atherosclerosis-prone mice fed with chow diet was sufficient to induce atherosclerosis without altering the lipid profile, and was linked to activation of both systemic and local innate and adaptive immunity and inflammation. Specifically, we found that ImP caused atherosclerosis through the imidazoline-1 receptor (I1R, also known as nischarin) in myeloid cells. Blocking this ImP-I1R axis inhibited the development of atherosclerosis induced by ImP or high-cholesterol diet in mice. Identification of the strong association of ImP with active atherosclerosis and the contribution of the ImP-I1R axis to disease progression opens new avenues for improving the early diagnosis and personalized therapy of atherosclerosis.
Repisalud
Publication Artículo científico (JournalArticle)

Embracing cancer complexity: Hallmarks of systemic disease.

  • Swanton, Charles
  • Bernard, Elsa
  • Abbosh, Chris
  • André, Fabrice
  • Auwerx, Johan
  • Balmain, Allan
  • Bar-Sagi, Dafna
  • Bernards, René
  • Bullman, Susan
  • DeGregori, James
  • Elliott, Catherine
  • Erez, Ayelet
  • Evan, Gerard
  • Febbraio, Mark A
  • Hidalgo, Andres
  • Jamal-Hanjani, Mariam
  • Joyce, Johanna A
  • Kaiser, Matthew
  • Lamia, Katja
  • Locasale, Jason W
  • Loi, Sherene
  • Malanchi, Ilaria
  • Merad, Miriam
  • Musgrave, Kathryn
  • Patel, Ketan J
  • Quezada, Sergio
  • Wargo, Jennifer A
  • Weeraratna, Ashani
  • White, Eileen
  • Winkler, Frank
  • Wood, John N
  • Vousden, Karen H
  • Hanahan, Douglas
The last 50 years have witnessed extraordinary developments in understanding mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical framework, our understanding of the molecular basis of systemic manifestations and the underlying causes of cancer-related death remains incomplete. Looking forward, elucidating how tumors interact with distant organs and how multifaceted environmental and physiological parameters impinge on tumors and their hosts will be crucial for advances in preventing and more effectively treating human cancers. In this perspective, we discuss complexities of cancer as a systemic disease, including tumor initiation and promotion, tumor micro- and immune macro-environments, aging, metabolism and obesity, cancer cachexia, circadian rhythms, nervous system interactions, tumor-related thrombosis, and the microbiome. Model systems incorporating human genetic variation will be essential to decipher the mechanistic basis of these phenomena and unravel gene-environment interactions, providing a modern synthesis of molecular oncology that is primed to prevent cancers and improve patient quality of life and cancer outcomes.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Activation of n-pentane while prolonging HZSM-5 catalyst lifetime during its combined reaction with methanol or dimethyl ether

  • Cordero-Lanzac, Tomás
  • Aguayo, Andrés T.
  • Castaño, Pedro
  • Bilbao, Javier
  • Martínez, Cristina|||0000-0002-4415-084X
  • Corma Canós, Avelino|||0000-0002-2232-3527
[EN] This work explores the synergies during combined reactions of n-pentane (nC5) with oxygenates (methanol or dimethyl ether, OX). The experimental runs have been carried out in a packed bed reactor at 500 °C, using a high silica HZSM-5 zeolite-based catalyst with different oxygenate-to-n-pentane (OX/nC5) ratios in the feed. A significant enhancement of the n-pentane conversion occurs for low OX/nC5 ratios in the feed (0.1¿0.25), especially when using dimethyl ether (DME). In addition, the presence of n-pentane reduces the rate of catalyst deactivation by coking during the conversion of oxygenates. These results have been explained on the grounds of a mechanistic interaction between the reactants: (1) the fast formation of methoxy and olefin intermediates from oxygenates, particularly from DME, could explain the promotion of n-pentane cracking, by facilitating the activation of the alkane by hydrogen transfer reactions; (2) the attenuation of deactivation during the conversion of oxygenates could be related to a lower extent of the arene cycle in the dual-cycle mechanism (limiting the polymethylbenzene formation). The analyses of used catalysts by means of temperature-programmed oxidation and confocal fluorescence microscopy have pointed out the higher reactivity of DME than that of methanol also for yielding coke structures., TC-L, ATA, PC and JB acknowledge the financial support received by the Spanish Ministry of Economy and Competitiveness with some ERDF funds (CTQ2016-77812-R,CTQ2016-79646-P), the Basque Government (IT1218-19) and the European Commission (HORIZON H2020-MSCA RISE-2018. Contract No. 823745). TC-L also acknowledges the Spanish Ministry of Education, Culture and Sport for the award of the FPU grant (FPU15-01666) and the additional mobility grant (EST17-00094). CM and AC acknowledge national and regional funding (MICINN/GVA) through `Severo Ochoa"(SEV-2016-0683), RTI2018-101033-B-I00 and AICO/2019/060 and financial support from EU by ERC-AdG-2014671093(SynCatMatch) and from the Fundacion Ramon Arecesthrough a research contract of the "Life and Materials Science" program. The authors also thank Dr. Ricardo Andrade of the SGIker of UPV/EHU for the support provided with the CFM technique.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Encapsulation of Palladium Carbide Subnanometric Species in Zeolite Boosts Highly Selective Semihydrogenation of Alkynes

  • Bai, Risheng
  • He, Guangyuan
  • Li, Lin
  • Zhang, Tianjun
  • Li, Junyan
  • Wang, Xingxing
  • Wang, Xiumei
  • Zou, Yongcun
  • Mei, Donghai
  • Yu, Jihong
  • Corma Canós, Avelino|||0000-0002-2232-3527
[EN] The selective hydrogenation of alkynes to alkenes is a crucial step in the synthesis of fine chemicals. However, the widely utilized palladium (Pd)-based catalysts often suffer from poor selectivity. In this work, we demonstrate a carbonization-reduction method to create palladium carbide subnanometric species within pure silicate MFI zeolite. The carbon species can modify the electronic and steric characteristics of Pd species by forming the predominant Pd-C-4 structure and, meanwhile, facilitate the desorption of alkenes by forming the Si-O-C structure with zeolite framework, as validated by the state-of-the-art characterizations and theoretical calculations. The developed catalyst shows superior performance in the selective hydrogenation of alkynes over mild conditions (298 K, 2 bar H-2), with 99 % selectivity to styrene at a complete conversion of phenylacetylene. In contrast, the zeolite-encapsulated carbon-free Pd catalyst and the commercial Lindlar catalyst show only 15 % and 14 % selectivity to styrene, respectively, under identical reaction conditions. The zeolite-confined Pd-carbide subnanoclusters promise their superior properties in semihydrogenation of alkynes., The authors thank the National Natural Science Foundation of China (Grant 21920102005, 22288101, 21835002, and 91961119), the National Key Research and Development Program of China (Grant 2021YFA1501202), the 111 Project (B17020), the European Union through the European Research Council (Grant ERC-AdG-2014-671093, SynCatMatch), and the Spanish Government through "Severo Ochoa" (SEV-2016-0683, MINECO) for supporting this work. R. B. thanks the National Natural Science Foundation of China (Grant 22201094) and the Jilin Youth Growth Science and Technology Plan Project (Grant 20230508189RC) for funding. The Centre for High-resolution Electron Microscopy (C & hstrok;EM), supported by SPST of ShanghaiTech University under Contract EM02161943 is acknowledged for their help on electron microscopy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Covalent Cross-Linking of 2H-MoS2 Nanosheets

  • Vázquez Sulleiro, M.
  • Quirós-Ovies, R.
  • Vera-Hidalgo, M.
  • Gómez, I.J.
  • Sebastián, V.
  • Santamaría, J.
  • Pérez, E.M.
The combination of 2D materials opens a wide range of possibilities to create new-generation structures with multiple applications. Covalently cross-linked approaches are a ground-breaking strategy for the formation of homo or heterostructures made by design. However, the covalent assembly of transition metal dichalcogenides flakes is relatively underexplored. Here, a simple covalent cross-linking method to build 2H-MoS2–MoS2 homostructures is described, using commercially available bismaleimides. These assemblies are mainly connected vertically, basal plane to basal plane, creating specific molecular sized spaces between MoS2 sheets. Therefore, this straightforward approach gives access to the controlled connection of sulfide-based 2D materials.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

High-Performance Thin-Layer Chromatography-Densitometry-Tandem ESI-MS to Evaluate Phospholipid Content in Exosomes of Cancer Cells

  • Sancho-Albero, María
  • Jarne, Carmen
  • Saviróon, María
  • Martín-Duque, Pilar
  • Membrado, Luis
  • Cebolla, Vicente L.
  • Santamaría, Jesús
The question of whether exosome lipids can be considered as potential cancer biomarkers faces our current limited knowledge of their composition. This is due to the difficulty in isolating pure exosomes, the variability of the biological sources from which they are extracted, and the uncertainty of the methods for lipid characterization. Here, we present a procedure to isolate exosomes and obtain a deep, repeatable, and rapid phospholipid (PL) composition of their lipid extracts, from embryonic murine fibroblasts (NIH-3T3 cell line) and none (B16-F1) and high (B16-F10) metastatic murine skin melanoma cells. The analytical method is based on High Performance Thin-Layer Chromatography with Ultraviolet and fluorescence densitometry and coupled to Electrospray (ESI)-tandem Mass Spectrometry (MS). Under the conditions described in this work, separation and determination of PL classes, (sphingomyelins, SM; phosphatidylcholines, PC; phosphatidylserines, PS; and phosphatidylethanolamines, PE) were achieved, expressed as mu g PL/100 mu g exosome protein, obtained by bicinchoninic acid assay (BCA). A detailed structural characterization of molecular species of each PL class was performed by simultaneous positive and negative ESI-MS and MS/MS directly from the chromatographic plate, thanks to an elution-based interface.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Exosomes loaded with ultrasmall Pt nanoparticles: a novel low-toxicity alternative to cisplatin

  • Sancho Albero, María
  • Martín-Pardillos, Ana
  • Lujan, Lluís
  • Sebastian, Víctor
  • Santamaria, Jesús
  • Martín Duque, Pilar
Background: Platinum nanoparticles have been demonstrated to have excellent anticancer properties. However, because of the lack of specificity they must be delivered to the tumor in amounts sufficient to reach the desired therapeutic objectives. Interestingly, exosomes are considered as excellent natural selective delivery nanotools, but until know their targeting properties have not being combined with the anticancer properties of platinum nanoparticles. Results: In this work we combine the targeting capabilities of exosomes and the antitumoral properties of ultrasmall (< 2 nm) platinum nanoparticles as a novel, low toxicity alternative to the use of cisplatin. A mild methodology based on the room temperature CO-assisted in situ reduction of Pt2+ precursor was employed to preserve the integrity of exosomes, while generating ultrasmall therapeutic PtNPs directly inside the vesicles. The resulting PtNPs-loaded exosomes constitute a novel hybrid bioartificial system that was readily internalized by the target cells inducing antiproliferative response, as shown by flow cytometry and microscopy experiments in vitro. In vivo Pt-Exos showed antitumoral properties similar to that of cisplatin but with a strongly reduced or in some cases no toxic effect, highlighting the advantages of this approach and its potential for translation to the clinic. Conclusions: In this study, a nanoscale vector based on ultrasmall PtNPs and exosomes has been created exhibiting antitumoral properties comparable or higher to those of the FDA approved cisplatin. The preferential uptake of PtNPs mediated by exosomal transfer between certain cell types has been exploited to create a selective antitumoral novel bioartificial system. We have demonstrated their anticancer properties both in vitro and in vivo comparing the results obtained with the administration of equivalent amounts of cisplatin, and showing a spectacular reduction of toxicity. © 2022, The Author(s).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Microwave-driven exfoliation of bulk 2H-MoS[sub]2 after acetonitrile prewetting produces large-area ultrathin flakes with exceptionally high yield

  • Quirós-Ovies, R.
  • Laborda, M.
  • Martín Sabanés, N.
  • Martín-Pérez, L.
  • Moreno Da-Silva, S.
  • Burzurí, E.
  • Sebastian, V.
  • Pérez, E. M.
  • Santamaría, J.
2D materials display exciting properties in numerous fields, but the development of applications is hindered by the low yields, high processing times, and impaired quality of current exfoliation methods. In this work we have used the excellent MW absorption properties of MoS2 to induce a fast heating that produces the near-instantaneous evaporation of an adsorbed, low boiling point solvent. The sudden evaporation creates an internal pressure that separates the MoS2 layers with high efficiency, and these are kept separated by the action of the dispersion solvent. Our fast method (90 s) gives high yields (47% at 0.2 mg/mL, 35% at 1 mg/mL) of highly exfoliated material (90% under 4 layers), large area (up to several μm2), and excellent quality (no significant MoO3 detected).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Reseña (Review)

Enzyme–iron oxide nanoassemblies: a review of immobilization and biocatalytic applications

  • Valls-Chivas, Ángeles
  • Gómez, Javier
  • Garcia-Peiro, Jose I.
  • Hornos, Felipe
  • Hueso, Jose L.
In the search for new biotechnological advances, increasing attention is currently being paid to the development of magnetic nanoplatforms loaded with enzymes, since, on the one hand, they can be recovered and reused, and on the other hand, they improve their catalytic activity and increase their stability, avoiding processes such as aggregation or autolysis. In this review, we evaluate a series of key parameters governing the enzyme–nanoparticle immobilization phenomena from a thermodynamic and kinetic point of view. We also focus on the use of magnetite nanoparticles (MNPs) as multifunctional vectors able to anchor enzymes, summarize the most relevant aspects of functionalization and immobilization and, finally, describe some recent and relevant applications of the enzyme–MNP hybrids as biocatalysts with especial emphasis on cancer therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Heterogeneous-driven glutathione oxidation: defining the catalytic role of chalcopyrite nanoparticles

  • Sánchez-Uriel, L.
  • Bonet-Aleta, J.
  • Ibarra, A.
  • Hueso, J. L.
Transition-metal nanocatalysis represents a novel alternative currently experiencing flourishing progress to tackle the tumor microenvironment (TME) in cancer therapy. These nanomaterials aim at attacking tumor cells using the intrinsic selectivity of inorganic catalysts. In addition, special attention to tune and control the release of these transition metals is also required. Understanding the chemical reactions behind the catalytic action of the transition-metal nanocatalysts and preventing potential undesired side reactions caused by acute cytotoxicity of the released ionic species represent another important field of research. Specifically, copper-based oxides may suffer from acute leaching that potentially may induce toxicity not only to target cancer cells but also to nearby cells and tissues. In this work, we propose the synthesis of chalcopyrite (CuFeS2) nanostructures capable of triggering two key reactions for an effective chemodynamic therapy (CDT) in the heterogeneous phase: (i) glutathione (GSH) oxidation and (ii) oxidation of organic substrates using H2O2, with negligible leaching of metals under TME-like conditions. This represents an appealing alternative toward the development of safer copper–iron-based nanocatalytic materials with an active catalytic response without incurring leaching side phenomena.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Unravelling the cell death mechanism triggered by catalytic copper–iron nanoparticles in vitro and in vivo

  • Encinas-Gimenez, Miguel
  • Martín-Pardillos, Ana
  • Bonet-Aleta, Javier
  • Pérez, Estela
  • Rodríguez-Largo, Ana
  • Hueso, Jose L.
  • Santamaria, Jesus
  • Martin-Duque, Pilar
Nanomedicine has developed an impressive array of anticancer devices, from drug delivery vectors to hyperthermia-enabling nanoparticles. Lately, emphasis has been shifted to the tumour microenvironment (TME) and to active nanomaterials adapted to the prevailing conditions. Among them, catalytic nanomaterials (also called nanocatalysts) represent a highly interesting alternative, especially when they are able to target metabolites that are present to a greater extent in tumoral cells, opening a window for a catalytically selective action. In this context, herein, we present an in-depth study of the working mechanisms of a meso-2,3-dimercaptosuccinic acid-coated, copper- and iron-based nanoparticle (CuFe@DMSA NPs) with high capability of glutathione (GSH) depletion with simultaneous production of reactive oxygen species (ROS). GSH is an important molecule with antioxidant properties, which is overexpressed in a broad range of tumoral cells, and these CuFe@DMSA NPs catalyse its conversion by means of leached copper ions. In this work, the metabolic action of this nanomaterial on tumoral cells has been thoroughly described, demonstrating that cells underwent a ferroptosis-like cell death, together with the arrest of the cell cycle and induction of apoptosis. The obtained in vitro results were further confirmed in vivo, showing that the increase of apoptosis leads to a significant reduction of tumour growth in treated mice.